The trend in neurological diseases in Moscow adolescents, before and after the COVID-19 pandemic

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Introduction. During the pandemic the stress level among adolescents has increased significantly due to the uncertainty of the future, awareness for the health of their friends and family, and changes in the educational process and daily routine. In addition, increased time spent indoors, lack of physical activity, poor nutrition and sleep disorders also contribute to the deterioration of the nervous system of adolescents.

It is necessary to conduct additional research and monitoring of the incidence of the nervous system among adolescents in the post-pandemic period to assess and prevent possible negative consequences on their health.

The purpose is to analyze the trend in the incidence of diseases of the nervous system in adolescents, including gender differences, using the example of Moscow over the period before and after the Covid-19 pandemic.

Materials and methods. The following methods are applied: summary and grouping, calculation of relative and average values, dynamics series, distribution indices, analysis of statistical aggregates. The data of the federal statistical observation form No. 12 “Information on the number of diseases registered in patients living in the service area of a medical institution” for 2016–2023 was used.

Results. Due to the COVID-19 pandemic in Moscow, there was an increase in the incidence during the “post-covid” period. In 2021–2023, the gain in the incidence of disorders of the autonomic nervous system (ANS) is twofold higher than over the five-year “pre-covid” period.

Research limitations. The study has regional (Moscow) limitations.

Conclusions. The average Moscow rates of the morbidity of the nervous system, while remaining lower than the Russian ones, are approaching them in trend. There were no significant changes in the difference between diseases in boys and girls, but in terms of episodic and paroxysmal disorders, the trend in convergence of indices was noted.

Compliance with ethical standards. The study does not require the submission of the conclusion of the biomedical ethics committee or other documents.

Acknowledgment. The study had no sponsorship.

Conflict of interest. The authors declare the absence of obvious and potential conflicts of interest in connection with the publication of this article.

Received: May 31, 2024 / Accepted: October 3, 2024 / Published: November 6, 2024

作者简介

Anastasia Podchernina

Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department

编辑信件的主要联系方式.
Email: podcherninaam@zdrav.mos.ru
ORCID iD: 0000-0002-8184-9705

Head of the Center for Medical Statistics, Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department, 115088, Moscow, Russian Federation

e-mail: podcherninaam@zdrav.mos.ru

参考

  1. Chen P.J., Pusica Y., Sohaei D., Prassas I., Diamandis E.P. An overview of mental health during the COVID-19 pandemic. Diagnosis (Berl.). 2021; 8(4): 403–12. https://doi.org/10.1515/dx-2021-0046
  2. Rubin G.J., Wessely S. The psychological effects of quarantining a city. BMJ. 2020; 368: m313. https://doi.org/10.1136/bmj.m313
  3. Altena E., Baglioni C., Espie C.A., Ellis J., Gavriloff D., Holzinger B., et al. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. J. Sleep Res. 2020; 29(4): e13052. https://doi.org/10.1111/jsr.13052
  4. Salova M.N., Zhdanova L.A., Shemanaeva E.V., Klepikova T.A. Impared health status in children suffered from new coronavirus infection. Vestnik Ivanovskoi meditsinskoi akademii. 2022; 27(1): 16–42. https://doi.org/10.52246/1606-8157_2022_27_1_16 https://elibrary.ru/ynhrmg (in Russian)
  5. Loshkova E.V., Mikhalenko I.V., Golikova E.V., Mikhalenko N.V., Rafikova Yu.S., Zhelev V.A. Dynamics of the incidence of chronic diseases in adolescents during the COVID-19 pandemic. Arkhiv pediatrii i detskoi khirurgii. 2023; 1(1): 19–30. https://doi.org/10.31146/2949-4664-apps-1-1-19-30 https://elibrary.ru/ywlvgi (in Russian)
  6. Ng Kee Kwong K.C., Mehta P.R., Shukla G., Mehta A.R. COVID-19, SARS and MERS: A neurological perspective. J. Clin. Neurosci. 2020; 77: 13–6. https://doi.org/10.1016/j.jocn.2020.04.124
  7. Desforges M., Le Coupanec A., Dubeau P., Bourgouin A., Lajoie L., Dubé M., et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019; 12(1): 14. https://doi.org/10.3390/v12010014
  8. Suto M., Takehara K., Morisaki N., Moriichi A., Gai R., Mori R. Disease trends in children and adolescents in Japan: a retrospective observational study using the nationwide claims data for 2012–2016. Children (Basel). 2024; 11(1): 81. https://doi.org/10.3390/children11010081
  9. Laçinel Gürlevik S., Günbey C., Ozsurekci Y., Oygar P.D., Kesici S., Gocmen R., et al. Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review. Eur. J. Paediatr. Neurol. 2022; 37: 139–54. https://doi.org/10.1016/j.ejpn.2022.02.003
  10. Singh S.K., Ruzek D., eds. Chapter 5. Human coronaviruses respiratory pathogens revisited as infectious neuroinvasive, neurotropic, and neurovirulent agents. In: Neuroviral Infections: RNA Viruses and Retroviruses. Boca Raton: CRC Press; 2013. https://doi.org/10.1201/b13908
  11. Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 2020; 92(6): 552–5. https://doi.org/10.1002/jmv.25728
  12. Ellul M.A., Benjamin L., Singh B., Lant S., Michael B.D., Easton A., et al. Neurological associations of COVID-19. Lancet Neurol. 2020; 19(9): 767–83. https://doi.org/10.1016/S1474-4422(20)30221-0
  13. Zubair A.S., McAlpine L.S., Gardin T., Farhadian S., Kuruvilla D.E., Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020; 77(8): 1018–27. https://doi.org/10.1001/jamaneurol.2020.2065
  14. Koralnik I.J., Tyler K.L. COVID-19: A global threat to the nervous system. Ann. Neurol. 2020; 88(1): 1–11. https://doi.org/10.1002/ana.25807
  15. Favas T.T., Dev P., Chaurasia R.N., Chakravarty K., Mishra R., Joshi D., et al. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol. Sci. 2020; 41(12): 3437–70. https://doi.org/10.1007/s10072-020-04801-y
  16. Montalvan V., Lee J., Bueso T., De Toledo J., Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin. Neurol. Neurosurg. 2020; 194: 105921. https://doi.org/10.1016/j.clineuro.2020.105921
  17. Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N. Engl. J. Med. 2020; 383(4): 334–46. https://doi.org/10.1056/NEJMoa2021680
  18. Ahmed M., Advani S., Moreira A., Zoretic S., Martinez J., Chorath K., et al. Multisystem inflammatory syndrome in children: a systematic review. EClinicalMedicine. 2020; 26: 100527. https://doi.org/10.1016/j.eclinm.2020.100527
  19. Aronoff S.C., Hall A., Del Vecchio M.T. The natural history of severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children: a systematic review. J. Pediatric. Infect. Dis. Soc. 2020; 9(6): 746–51. https://doi.org/10.1093/jpids/piaa112
  20. Kaushik A., Gupta S., Sood M., Sharma S., Verma S. A systematic review of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection. Pediatr. Infect. Dis. J. 2020; 39(11): e340–6. https://doi.org/10.1097/INF.0000000000002888
  21. Abrams J.Y., Godfred-Cato S.E., Oster M.E., Chow E.J., Koumans E.H., Bryant B., et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. J. Pediatr. 2020; 226: 45–54.e1. https://doi.org/10.1016/j.jpeds.2020.08.003
  22. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci. Biobehav. Rev. 2003; 27(1–2): 3–18. https://doi.org/10.1016/s0149-7634(03)00005-8
  23. Khandaker G., Jung J., Britton P.N., King C., Yin J.K., Jones C.A. Long-term outcomes of infective encephalitis in children: a systematic review and meta-analysis. Dev. Med. Child Neurol. 2016; 58(11): 1108–15. https://doi.org/10.1111/dmcn.13197

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © , 2024


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ:  ПИ № ФС77-50668 от 13.07.2012 г.